Literature DB >> 12682835

Anti-C5a monoclonal antibodies and pulmonary polymorphonuclear leukocyte infiltration--endothelial dysfunction by venous gas embolism.

Vibeke Nossum1, Astrid Hjelde, Kåre Bergh, Anne-Lise Ustad, Alf O Brubakk.   

Abstract

Venous gas embolism (VGE) impairs endothelial function although there is no apparent mechanical damage to the endothelial layer. We investigated whether a monoclonal antibody against the complement anaphylatoxine C5a would affect endothelial dysfunction and pulmonary polymorphonuclear leukocyte infiltration caused by low-grade VGE. Six rabbits were pre-treated with the anti-C5a monoclonal antibody whereas a sham monoclonal antibody was administrated to six other animals 30 min before VGE. Six untreated rabbits subjected to an identical protocol except antibody treatment were used for control. The monoclonal anti-C5a antibody reduced PMN infiltration compared to the control group ( P<0.03). There were no major signs of apoptosis in endothelial cells inside the pulmonary artery in any of the examined animals. There was reduced PMN infiltration and improved endothelium-dependent relaxation in the sham-antibody group, these effects were however not significant. In conclusion, anti-C5a protects the endothelium against injury caused by small amounts of gas bubbles.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682835     DOI: 10.1007/s00421-003-0804-8

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  32 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.

Authors:  K Bergh; O J Iversen
Journal:  Scand J Immunol       Date:  1989-03       Impact factor: 3.487

3.  Activation of complement at plasma-air or serum-air interface of rabbits.

Authors:  C A Ward; A Koheil; D McCullough; W R Johnson; W D Fraser
Journal:  J Appl Physiol (1985)       Date:  1986-05

4.  A review of blood changes associated with compression-decompression: relationship to decompression sickness.

Authors:  R B Philp
Journal:  Undersea Biomed Res       Date:  1974-06

5.  Quantification of damage by air emboli to lung microvessels in anesthetized sheep.

Authors:  K H Albertine; J P Wiener-Kronish; K Koike; N C Staub
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-11

6.  Carbon dioxide field flooding minimizes residual intracardiac air after open heart operations.

Authors:  W R Webb; L H Harrison; F R Helmcke; A Camino-Lopez; N A Munfakh; H A Heck; P V Moulder
Journal:  Ann Thorac Surg       Date:  1997-11       Impact factor: 4.330

7.  Lack of effect of anti-C5a monoclonal antibody on endothelial injury by gas bubbles in the rabbit after decompression.

Authors:  V Nossum; A Hjelde; K Bergh; A O Brubakk
Journal:  Undersea Hyperb Med       Date:  2000       Impact factor: 0.698

8.  Lower decompression sickness risk in rats by intravenous injection of foreign protein.

Authors:  S R Kayar; E O Aukhert; M J Axley; L D Homer; A L Harabin
Journal:  Undersea Hyperb Med       Date:  1997       Impact factor: 0.698

9.  Human C5a des Arg increases vascular permeability.

Authors:  P J José; M J Forrest; T J Williams
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

10.  Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).

Authors:  R Huey; T E Hugli
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

View more
  1 in total

Review 1.  Venous gas embolism as a predictive tool for improving CNS decompression safety.

Authors:  A Møllerløkken; S E Gaustad; M B Havnes; C R Gutvik; A Hjelde; U Wisløff; A O Brubakk
Journal:  Eur J Appl Physiol       Date:  2011-05-19       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.